Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients:Correlation With Disease Activity and Chronic Organ Damage in These Patients
Recruiting · NCT06718283 · Observational (researchers observe without assigning treatment) · Lead sponsor: Sohag University
View the official record on ClinicalTrials.gov →What this trial is about
The study aim to evaluate the relationship between some important hematologic indices in juvenile lupus erythematosus patients and if these indices may be use as markers of disease acitivity in these patients or not ,also evaluate the relationship with these markers and chronic organ damage index
Who can take part
Age range
Up to 18 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- patients who fillful 2012 SLICC criteria or 2019 ACR/EULAR criteria of systemic lupus erythematosus
- Age of patients at disease onset before 18 years
Exclusion criteria
- Adult onset disease ( age at disease onset after 18 years
- Any other chronic inflamatory disorders or other autoimmune diseases
Where it is running
1 location listed.
- Faculty of medicine - Sohag, Egypt